!!Thomas Eschenhagen - Curriculum Vitae *1978-1986 Hannover Medical School (MHH), degree physician\\ *1988 Medical thesis (PhD equivalent) Hannover Medical School\\ *1992 Molecular Biology Diploma, University of Hamburg\\ *1994 Habilitation, University of Hamburg\\ *1995 Approval as specialist in Pharmacology and Toxicology, Physician´s Board Hamburg\\ *1997 Approval as specialist in Clinical Pharmacology, Physician´s Board Hamburg\\ *1994-1998 Heisenberg grant DFG, Visiting scientist in Washington University, St. Louis, USA, Stanford Research Center, Menlo Park, USA, National Institute of Ageing, NIH, Baltimore, USA, Universite Paris 11, INSERM U-446, Chatenay Malabry, France \\ __Research support and activities in research consortia (selection)__ \\ *2000-2002 Coordinator and speaker, DFG Graduate School 750, University of Erlangen "Vascular damage in kidney and heart"\\ *2005-2011 Coordinator and speaker, DFG Research Group FOR 604 "Signaling pathways in the healthy and diseased heart", University of Hamburg\\ *2004-2009 Core member Fondation LeDucq Transatlantic Networks of Excellence "Cardiac Progenitors Transatlantic Alliance" (ccordinators K. Schwartz, K. Chien) \\ *2015-2019 German Centre for Cardiovascular Research DZHK, Partner site Hamburg/Kiel/Lübeck, PI Eschenhagen\\ *2013-2017 British Heart Foundation (coordinator S. Harding, ICL, UK) Regenerative Medicine Centres, PI Eschenhagen\\ *2013-2019 ERC AG "IndivuHeart - individualized risk assessment with hiPSC-derived engineered heart tissue"\\ *2014-2017 British National Centre for the Reduction of Animal Experiments (NCR) CRACK-IT Challenges "Engineered 2D & 3D hiPSC-CM platforms to detect cardiovascular safety liabilities (coordinator C. Denning, Nottingham, UK), PI Eschenhagen\\ *2016-2018 EU Horizon 2020 ITN "Atrial Fibrillation (coordinator T. Jespersen, Kopenhagen, DK), PI Christ and Eschenhagen\\ *2017-2020 ERA-CVD "Variation" (coordinator Y. Pinto, Amsterdam, NL), PI Eschenhagen \\ __Activities on knowledge management__ \\ *Board member German Heart Association (2003), German Association for Chronic Diseases (2005), Galenus von Pergamon *Award Committee (2012), German Physician´s Drug Commission (2008), European Society of Cardiology Heart Failure Association (2006-2012)\\ *Editorial Board membership J Mol Cell Cardiol; Bas Res Cardiol, Clin Res Cardiol, Cardiovasc Res (Associate Editor 20014-2016)\\ *Associate Editor, Circulation (since 2016)\\ *2004-2012 Member DFG Selection panel for Cardiovascular Research\\ *2012-2017 Member DFG Selection panel for Collaborative Research Centers (SFB)\\ *Reviewer for British Heart Foundation (e.g. Excellence Centres), Netherlands Academy of Science (ICIN Evaluation), Austrian Science Board, INSERM and others\\ *2004 Organizer of EU Workshop on "The Future of Young Scientists in Cardiovascular Research"\\ *Since 2006 Organizer/coorganizer of the ESC-HFA Winter Meeting on Translational Heart Failure Research)\\ *2006 Member of roadmap procedures for the NIH (stem cells) and the German Ministry of Education and Research (BMBF) and the EU\\ *2008-2012 Speaker of the Scientific Advisory Board of the Leibniz Institute of Arteriosclerosis Research (LIFA) in Münster\\ *Speaker DZHK (since 2011)\\ *2017 Coorganizer of the Annual Meeting of the ISHR European Section, Hamburg (main organizer L. Carrier)\\ *2018 Coorganizer of the Gordon Research Conference on Cardiac Regulatory Mechanisms\\ *2018 President of the Annual Meeting of the German Society for Cardiology (DGK, Mannheim)\\ \\